Organization · Venture Capital
Fountain Healthcare Partners
Fountain Healthcare Partners is a venture capital firm based in Dublin, Ireland, and New York, specializing in early-stage investments in life sciences companies across Europe and the United States.
Overview
What Fountain Healthcare Partners does
What Fountain Healthcare Partners is
Fountain Healthcare Partners is a venture capital firm based in Dublin, Ireland, and New York, specializing in early-stage investments in life sciences companies across Europe and the United States.
How it participates in the startup ecosystem
The current public profile supports funder capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Venture Capital
- Founded
- Founded in 2008
- Approximate age
- About 18 years
- Structured capabilities
- Funder
- Last reviewed
- March 27, 2026
Official channels
Find Fountain Healthcare Partners elsewhere
Open the official website or a supported primary organization account.
Capability profile
Fountain Healthcare Partners as a funder
Investment thesis
Fountain Healthcare Partners is dedicated to supporting innovative healthcare solutions in the life sciences sector, focusing on seed and early-stage investments with the potential for significant exits within 3 to 6 years.
Focus narrative
The fund primarily invests in specialty pharmaceuticals, biopharmaceuticals, medical devices, and diagnostics. Fountain Healthcare Partners targets seed and early-stage companies that demonstrate the potential for significant growth and successful exits within a 3 to 6-year timeframe.
Value beyond capital
Fountain Healthcare Partners adds value to its portfolio companies through strategic guidance, industry expertise, and access to a broad network of resources in the life sciences sector. The team leverages their extensive experience in venture capital and healthcare to support the growth and success of their investments.
Focus and fit
- Stages
- Seed
- Sectors
- Biotech · Healthcare · Medical Devices · Diagnostics · Pharma Tech
- Regions
- EuropeNorth America
Availability
- Currently deploying
- Yes
Portfolio and track record
- Recorded notable exits
- Calypso Biotech, KaNDy Therapeutics, Neuravi, Civitas Therapeutics, and Genable
Portfolio context
Fountain Healthcare Partners has invested in notable companies such as: Exciva: Developing a therapy for neuropsychiatric symptoms of dementia. Inotrem: Focused on immunomodulation targeting the TREM-1 pathway for inflammatory responses. Mainstay Medical: Commercializing a neurostimulation system for chronic low back pain. Calypso Biotech: An immunotherapy company developing monoclonal antibodies for immune pathologies, acquired by Novartis in January 2024. XyloCor Therapeutics: Developing gene therapy for advanced coronary artery disease. Corteria Pharmaceuticals: A spin-off from Sanofi, developing drugs for heart failure. Dualyx: A Belgian biotech company focused on Treg-based therapies for autoimmune diseases.
Common questions
What to know about Fountain Healthcare Partners
Upseed classifies Fountain Healthcare Partners under the Venture Capital organization type. Its current public profile includes funder capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
March 27, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.